Position in GRFS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,732
-$119 QoQ
Shares Held
216
+9.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sound Income Strategies, LLC holds $77,276,482 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
96,903 | $24,384,670 | |
| 2 | PFE |
Pfizer Inc
|
805,732 | $19,402,026 | |
| 3 | GSK |
GSK plc
|
339,055 | $17,773,263 | |
| 4 | LLY |
ELI LILLY & Co
|
5,822 | $6,983,082 | |
| 5 | SNY |
Sanofi
|
90,957 | $3,880,225 | |
| 6 | JNJ |
Johnson & Johnson
|
9,354 | $2,375,635 | |
| 7 | AMGN |
Amgen Inc
|
2,246 | $813,321 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,917 | $631,834 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,732 | 216 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,851 | 198 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||